XML 24 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Business Restructuring Charges
 9 Months Ended
Jun. 30, 2018
Restructuring and Related Activities [Abstract]  
Business Restructuring Charges
Business Restructuring Charges
In connection with the Company's acquisition of Bard, the 2015 acquisition of CareFusion and other portfolio rationalization initiatives, the Company incurred restructuring costs during the nine months ended June 30, 2018, which were recorded as Acquisitions and other restructurings. Restructuring liability activity for the nine months ended June 30, 2018 was as follows:
(Millions of dollars)
Employee
Termination
 
Other
 
Total
 
Bard
 
CareFusion/Other Initiatives
 
Bard (a)
 
CareFusion/Other Initiatives
 
Bard
 
CareFusion/Other Initiatives
Balance at September 30, 2017
$
—

 
$
49

 
$
—

 
$
6

 
$
—

 
$
55

Charged to expense
126

 
30

 
118

 
14

 
244

 
44

Cash payments
(60
)
 
(49
)
 
—

 
(14
)
 
(60
)
 
(63
)
Non-cash settlements
—

 
—

 
(118
)
 
—

 
(118
)
 
—

Balance at June 30, 2018
$
66

 
$
30

 
—

 
$
6

 
$
66

 
$
36


(a)
Represents the cost associated with the conversion of certain pre-acquisition equity awards of Bard to BD equity awards as well as costs relating to Bard’s pension plan, partially offset by a gain on the sale of the Company's soft tissue core needle biopsy product line which was recorded in the second quarter of fiscal year 2018.